$HZNP Headlines Why this year’s rally is not
Post# of 88926
Posted On: 08/16/2014 9:59:59 AM
$HZNP Headlines
Why this year’s rally is not the same as last year’s 2:27 p.m. July 15, 2014 - The Trading Deck
Stocks are poised for a jump higher 12:30 p.m. June 10, 2014 - The Trading Deck
Two health-care names ready to run 12:28 p.m. June 5, 2014 - The Trading Deck
6 stocks to watch 3:13 p.m. June 4, 2014 - The Trading Deck
Charting a bullish second-quarter backdrop 12:34 p.m. April 1, 2014 - Michael Ashbaugh
Charting a bullish second-quarter backdrop 12:20 p.m. April 1, 2014 - Michael Ashbaugh
S&P 500 retests major support 12:47 p.m. March 27, 2014 - Michael Ashbaugh
Thursday’s biggest gaining and declining stocks 4:27 p.m. Sept. 20, 2012 - Greg Morcroft
Horizon Pharma prices offering at steep discount 9:54 a.m. Sept. 20, 2012 - MarketWatch.com
Five companies detail stock offerings 9:39 a.m. Sept. 20, 2012 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 6:54 a.m. Aug. 10, 2012 - MarketWatch
Horizon Pharma down 18% following drug approval 10:59 a.m. July 27, 2012 - Val Brickates Kennedy
Horizon Pharma opens flat post-IPO 12:00 p.m. July 28, 2011 - MarketWatch.com
Horizon Pharma: Upbeat 2015 Guidance Increases Confidence 8:35 a.m. Aug. 11, 2014 - Seeking Alpha
Horizon Pharma Offers Update on Effectiveness of S-4 Registration 6:32 a.m. Aug. 8, 2014 - benzinga.com
Horizon Pharma's (HZNP) CEO Tim Walbert on Q2 2014 Results - Earnings Call Transcript 2:09 p.m. Aug. 7, 2014 - Seeking Alpha
Horizon Pharma (HZNP) Q2 2014 Results - Earnings Call Webcast 7:55 a.m. Aug. 7, 2014 - Seeking Alpha
10-Q: HORIZON PHARMA, INC. 6:53 a.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notable earnings before Thursday’s open 5:30 p.m. Aug. 6, 2014 - Seeking Alpha
Will Horizon Pharma (HZNP) Earnings Miss Estimates in Q2? - Analyst Blog 5:00 p.m. Aug. 6, 2014 - Zacks.com
Great Buying Opportunity In Pozen Shares 10:11 a.m. July 30, 2014 - Seeking Alpha
Why Horizon Pharmaceuticals (HZNP) Is Plummeting Today 2:25 p.m. July 28, 2014 - TheStreet.com
Horizon Pharma Shares Fall as Drugs Added to Exclusion List 12:33 p.m. July 28, 2014 - The Wall Street Journal Interactive Edition
Access to Horizon Pharma Drugs Cut By Two Leading PBMs 10:56 a.m. July 28, 2014 - TheStreet.com
Horizon Pharma Drugs Ditched By Pharmacies; Stock Falls 10:14 a.m. July 28, 2014 - Investors Business Daily
Update: Horizon Pharma's Duexis And Vimovo To Be Taken Off Formularies By Express Scripts And CVS Caremark In 2015 9:18 a.m. July 28, 2014 - Seeking Alpha
Two PBMs drop Horizon NSAIDs 9:03 a.m. July 28, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – HZNP ARNA GB SGEN 2:15 p.m. July 10, 2014 - InvestorPlace.com
5 Newly Profitable Stocks to Buy – Screen of the Week 6:59 a.m. July 9, 2014 - InvestorPlace.com
A Company's First Profit Can Mean Big Profits to Investors - Screen of the Week 2:11 a.m. July 8, 2014 - Zacks.com
Salix Pharmaceuticals Surges on Positive IBS Data - Analyst Blog 6:15 p.m. July 2, 2014 - Zacks.com
Amgen Gets Breakthrough Therapy Status for Leukemia Drug - Analyst Blog 5:55 p.m. July 2, 2014 - Zacks.com
Hottest Healthcare Stocks Now – IRWD IPXL EXAM HZNP 2:00 p.m. June 19, 2014 - InvestorPlace.com
Horizon Pharma Announces U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen / esomeprazole) Delayed Release Tablets 7:31 a.m. Aug. 13, 2014 - Marketwire
Critical Alerts For Stratasys, Horizon Pharma, Isis Pharmaceuticals, Amgen, and Discover Financial Services Released By InvestorsObserver 9:31 a.m. Aug. 8, 2014 - PR Newswire - PRF
Horizon Pharma Announces Effectiveness of S-4 Registration Statement for Acquisition of Vidara Therapeutics International Public Company Limited 7:31 a.m. Aug. 8, 2014 - Marketwire
Horizon Pharma Reports Second Quarter 2014 Financial Results and Provides Business Update 6:31 a.m. Aug. 7, 2014 - Marketwire
Technical Analysis on Pharma Equities -- Mylan, AVANIR Pharma, Horizon Pharma, VIVUS, and Auxilium Pharma 9:10 a.m. Aug. 6, 2014 - PR Newswire - PRF
Horizon Pharma Announces the U.S. Patent and Trademark Office Issuance of Additional Notices of Allowance With Claims Covering VIMOVO(R) (Naproxen / Esomeprazole) Delayed Release Tablets 7:31 a.m. Aug. 5, 2014 - Marketwire
Complete Response Letter from FDA, Positive Opinion on Drug, Technical Update, Financial Result Release, and Clinical Trial Results - Research Reports on AcelRx, Horizon, Gilead, AbbVie and Exelixis 9:20 a.m. July 31, 2014 - PR Newswire - PRF
Horizon Pharma to Host Conference Call and Webcast to Discuss Second Quarter 2014 Financial Results on August 7, 2014 7:30 a.m. July 29, 2014 - Marketwire
Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt 6:50 a.m. July 2, 2014 - PR Newswire - PRF
Market Expansion, Merger Agreements, Management Transitions, and Market Activity - Analyst Notes on Intuitive Surgical, Auxilium, Horizon Pharma, Tesaro and ArQule 6:30 a.m. July 2, 2014 - PR Newswire - PRF
Horizon Pharma Announces Execution of $300 Million Senior Secured Credit Agreement in Connection With the Proposed Acquisition of Vidara 7:01 a.m. June 19, 2014 - Marketwire
Horizon Pharma Announces Robert J. De Vaere to Retire and Names Paul W. Hoelscher Chief Financial Officer 7:01 a.m. June 18, 2014 - Marketwire
Horizon Pharma to Present at the JMP Securities Healthcare Conference 2014 3:25 p.m. June 17, 2014 - Marketwire
Consent Expiry Extensions, Collaborations, Grants, Conference Presentations, and FDA Approvals - Analyst Notes on Forest Laboratories, Intuitive Surgical, Horizon Pharma, Cubist and BDSI 6:10 a.m. June 12, 2014 - PR Newswire - PRF
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:45 p.m. June 6, 2014 - Marketwire
Top Gainers Roundup -- Research on Horizon Pharma, Celldex Therapeutics, Extreme Networks, and WidePoint 6:17 a.m. May 28, 2014 - PR Newswire - PRF
Horizon Pharma to Present at the Jefferies 2014 Global Healthcare Conference 7:31 a.m. May 27, 2014 - Marketwire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 5:11 p.m. May 23, 2014 - Marketwire
Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co. 7:20 a.m. May 16, 2014 - PR Newswire - PRF
Horizon Pharma Reports First Quarter 2014 Financial Results Exceeding Expectations and Raises 2014 Full-Year Guidance 6:31 a.m. May 9, 2014 - Marketwire
Why this year’s rally is not the same as last year’s 2:27 p.m. July 15, 2014 - The Trading Deck
Stocks are poised for a jump higher 12:30 p.m. June 10, 2014 - The Trading Deck
Two health-care names ready to run 12:28 p.m. June 5, 2014 - The Trading Deck
6 stocks to watch 3:13 p.m. June 4, 2014 - The Trading Deck
Charting a bullish second-quarter backdrop 12:34 p.m. April 1, 2014 - Michael Ashbaugh
Charting a bullish second-quarter backdrop 12:20 p.m. April 1, 2014 - Michael Ashbaugh
S&P 500 retests major support 12:47 p.m. March 27, 2014 - Michael Ashbaugh
Thursday’s biggest gaining and declining stocks 4:27 p.m. Sept. 20, 2012 - Greg Morcroft
Horizon Pharma prices offering at steep discount 9:54 a.m. Sept. 20, 2012 - MarketWatch.com
Five companies detail stock offerings 9:39 a.m. Sept. 20, 2012 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 6:54 a.m. Aug. 10, 2012 - MarketWatch
Horizon Pharma down 18% following drug approval 10:59 a.m. July 27, 2012 - Val Brickates Kennedy
Horizon Pharma opens flat post-IPO 12:00 p.m. July 28, 2011 - MarketWatch.com
Horizon Pharma: Upbeat 2015 Guidance Increases Confidence 8:35 a.m. Aug. 11, 2014 - Seeking Alpha
Horizon Pharma Offers Update on Effectiveness of S-4 Registration 6:32 a.m. Aug. 8, 2014 - benzinga.com
Horizon Pharma's (HZNP) CEO Tim Walbert on Q2 2014 Results - Earnings Call Transcript 2:09 p.m. Aug. 7, 2014 - Seeking Alpha
Horizon Pharma (HZNP) Q2 2014 Results - Earnings Call Webcast 7:55 a.m. Aug. 7, 2014 - Seeking Alpha
10-Q: HORIZON PHARMA, INC. 6:53 a.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notable earnings before Thursday’s open 5:30 p.m. Aug. 6, 2014 - Seeking Alpha
Will Horizon Pharma (HZNP) Earnings Miss Estimates in Q2? - Analyst Blog 5:00 p.m. Aug. 6, 2014 - Zacks.com
Great Buying Opportunity In Pozen Shares 10:11 a.m. July 30, 2014 - Seeking Alpha
Why Horizon Pharmaceuticals (HZNP) Is Plummeting Today 2:25 p.m. July 28, 2014 - TheStreet.com
Horizon Pharma Shares Fall as Drugs Added to Exclusion List 12:33 p.m. July 28, 2014 - The Wall Street Journal Interactive Edition
Access to Horizon Pharma Drugs Cut By Two Leading PBMs 10:56 a.m. July 28, 2014 - TheStreet.com
Horizon Pharma Drugs Ditched By Pharmacies; Stock Falls 10:14 a.m. July 28, 2014 - Investors Business Daily
Update: Horizon Pharma's Duexis And Vimovo To Be Taken Off Formularies By Express Scripts And CVS Caremark In 2015 9:18 a.m. July 28, 2014 - Seeking Alpha
Two PBMs drop Horizon NSAIDs 9:03 a.m. July 28, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – HZNP ARNA GB SGEN 2:15 p.m. July 10, 2014 - InvestorPlace.com
5 Newly Profitable Stocks to Buy – Screen of the Week 6:59 a.m. July 9, 2014 - InvestorPlace.com
A Company's First Profit Can Mean Big Profits to Investors - Screen of the Week 2:11 a.m. July 8, 2014 - Zacks.com
Salix Pharmaceuticals Surges on Positive IBS Data - Analyst Blog 6:15 p.m. July 2, 2014 - Zacks.com
Amgen Gets Breakthrough Therapy Status for Leukemia Drug - Analyst Blog 5:55 p.m. July 2, 2014 - Zacks.com
Hottest Healthcare Stocks Now – IRWD IPXL EXAM HZNP 2:00 p.m. June 19, 2014 - InvestorPlace.com
Horizon Pharma Announces U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen / esomeprazole) Delayed Release Tablets 7:31 a.m. Aug. 13, 2014 - Marketwire
Critical Alerts For Stratasys, Horizon Pharma, Isis Pharmaceuticals, Amgen, and Discover Financial Services Released By InvestorsObserver 9:31 a.m. Aug. 8, 2014 - PR Newswire - PRF
Horizon Pharma Announces Effectiveness of S-4 Registration Statement for Acquisition of Vidara Therapeutics International Public Company Limited 7:31 a.m. Aug. 8, 2014 - Marketwire
Horizon Pharma Reports Second Quarter 2014 Financial Results and Provides Business Update 6:31 a.m. Aug. 7, 2014 - Marketwire
Technical Analysis on Pharma Equities -- Mylan, AVANIR Pharma, Horizon Pharma, VIVUS, and Auxilium Pharma 9:10 a.m. Aug. 6, 2014 - PR Newswire - PRF
Horizon Pharma Announces the U.S. Patent and Trademark Office Issuance of Additional Notices of Allowance With Claims Covering VIMOVO(R) (Naproxen / Esomeprazole) Delayed Release Tablets 7:31 a.m. Aug. 5, 2014 - Marketwire
Complete Response Letter from FDA, Positive Opinion on Drug, Technical Update, Financial Result Release, and Clinical Trial Results - Research Reports on AcelRx, Horizon, Gilead, AbbVie and Exelixis 9:20 a.m. July 31, 2014 - PR Newswire - PRF
Horizon Pharma to Host Conference Call and Webcast to Discuss Second Quarter 2014 Financial Results on August 7, 2014 7:30 a.m. July 29, 2014 - Marketwire
Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt 6:50 a.m. July 2, 2014 - PR Newswire - PRF
Market Expansion, Merger Agreements, Management Transitions, and Market Activity - Analyst Notes on Intuitive Surgical, Auxilium, Horizon Pharma, Tesaro and ArQule 6:30 a.m. July 2, 2014 - PR Newswire - PRF
Horizon Pharma Announces Execution of $300 Million Senior Secured Credit Agreement in Connection With the Proposed Acquisition of Vidara 7:01 a.m. June 19, 2014 - Marketwire
Horizon Pharma Announces Robert J. De Vaere to Retire and Names Paul W. Hoelscher Chief Financial Officer 7:01 a.m. June 18, 2014 - Marketwire
Horizon Pharma to Present at the JMP Securities Healthcare Conference 2014 3:25 p.m. June 17, 2014 - Marketwire
Consent Expiry Extensions, Collaborations, Grants, Conference Presentations, and FDA Approvals - Analyst Notes on Forest Laboratories, Intuitive Surgical, Horizon Pharma, Cubist and BDSI 6:10 a.m. June 12, 2014 - PR Newswire - PRF
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:45 p.m. June 6, 2014 - Marketwire
Top Gainers Roundup -- Research on Horizon Pharma, Celldex Therapeutics, Extreme Networks, and WidePoint 6:17 a.m. May 28, 2014 - PR Newswire - PRF
Horizon Pharma to Present at the Jefferies 2014 Global Healthcare Conference 7:31 a.m. May 27, 2014 - Marketwire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 5:11 p.m. May 23, 2014 - Marketwire
Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co. 7:20 a.m. May 16, 2014 - PR Newswire - PRF
Horizon Pharma Reports First Quarter 2014 Financial Results Exceeding Expectations and Raises 2014 Full-Year Guidance 6:31 a.m. May 9, 2014 - Marketwire
(0)
(0)Scroll down for more posts ▼